High-risk cardiac patients can take a breath: Moving Analytics’ virtual cardiac rehabilitation program got a 20-million dollar boost. With heart […]
Category: Startup News
Deep Blue Medical Advances Goes Deep
Deep Blue Medical’s T-Line® Hernia Mesh, with the close of its Series A1 funding round, will address an increasingly larger and more demanding market for superior hernia repair technology.
Grin And Show It
Ever struggled with braces, neck gear, or aligners? These problems might be a thing of the past. Brius’ new technology, […]
Is Chronic Pain Getting On Your Last Nerve?
A step forward for NeuraLace Medical, Inc. means a step forward for chronic pain patients everywhere. The AMA’s recent approval […]
911, What’s Your Emergency
Emergency services aren’t the same for everyone. But Shanel Fields and MD Ally are working to change that by giving 911 callers more options. MD Ally is the first platform of its kind, and it’s expanding across the country — for good reason.
Novela’s Novel Assets
Wearable epilepsy technology takes a step forward with Novela’s acquisition of seizure-detection assets from the aptly-named Brain Sentinel.
Juneteenth: A Conversation with Scripted Founder James Lott
Having more Black individuals in positions of power helps to rectify the racial bias present in healthtech. Why not give people who have different perspectives an opportunity?
After All, It’s Not Rocket Science
Brain surgeons may have one of the two toughest jobs in the world, but at least companies like Invenio are developing the technology to make cancer detection and removal safer, more accurate, and more efficient.
Enspectra Health Announces New Vision Trial and Partnership With Golden State Dermatology
With real-time evaluation across the surface of the skin, Enspectra’s technology holds the potential to reduce unnecessary biopsies and allow clinicians to examine suspicious lesions earlier.
Invenio Imaging Receives CE Mark to Detect Cancer at the Time of Surgery using Artificial Intelligence
NIO Glioma Reveal is based on deep learning and allows neurosurgeons to identify areas of cancer infiltration in patients undergoing primary treatment of a diffuse glioma.